Cite
HARVARD Citation
Montejano, R. et al. (2023). Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial. Clinical infectious diseases. pp. e116-e125. [Online].